BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Juanola O, Ferrusquía-Acosta J, García-Villalba R, Zapater P, Magaz M, Marín A, Olivas P, Baiges A, Bellot P, Turon F, Hernández-Gea V, González-Navajas JM, Tomás-Barberán FA, García-Pagán JC, Francés R. Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis. FASEB J 2019;33:11595-605. [PMID: 31345057 DOI: 10.1096/fj.201901327R] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Rhee SJ, Kim H, Lee Y, Lee HJ, Park CHK, Yang J, Kim YK, Ahn YM. The association between serum microbial DNA composition and symptoms of depression and anxiety in mood disorders. Sci Rep 2021;11:13987. [PMID: 34234173 DOI: 10.1038/s41598-021-93112-z] [Reference Citation Analysis]
2 Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. Int J Mol Sci. 2020;21:5254. [PMID: 32722100 DOI: 10.3390/ijms21155254] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
3 Sharma SP, Suk KT, Kim DJ. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases. World J Gastroenterol 2021; 27(37): 6161-6179 [PMID: 34712025 DOI: 10.3748/wjg.v27.i37.6161] [Reference Citation Analysis]
4 Lang S, Schnabl B. Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. Cell Host Microbe 2020;28:233-44. [PMID: 32791115 DOI: 10.1016/j.chom.2020.07.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
5 Bajaj JS, Ng SC, Schnabl B. Promises of microbiome-based therapies. J Hepatol 2022;76:1379-91. [PMID: 35589257 DOI: 10.1016/j.jhep.2021.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Maslennikov R, Ivashkin V, Efremova I, Poluektova E, Shirokova E. Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link? World J Clin Cases 2021;9:9320-32. [PMID: 34877269 DOI: 10.12998/wjcc.v9.i31.9320] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhou J, Tripathi M, Sinha RA, Singh BK, Yen PM. Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease. Hepatoma Res 2021;7:11. [PMID: 33490737 DOI: 10.20517/2394-5079.2020.134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu H, Chiou J. Potential Benefits of Probiotics and Prebiotics for Coronary Heart Disease and Stroke. Nutrients 2021;13:2878. [PMID: 34445037 DOI: 10.3390/nu13082878] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xu Y, Bolvig AK, McCarthy-Sinclair B, Marco ML, Bach Knudsen KE, Hedemann MS, Lærke HN. The role of rye bran and antibiotics on the digestion, fermentation process and short-chain fatty acid production and absorption in an intact pig model. Food Funct 2021;12:2886-900. [PMID: 33877244 DOI: 10.1039/d1fo00213a] [Reference Citation Analysis]
10 Li X, Dong L, Li A, Yi J, Brotto M, Zhou J. Butyrate Ameliorates Mitochondrial Respiratory Capacity of The Motor-Neuron-like Cell Line NSC34-G93A, a Cellular Model for ALS. Biomolecules 2022;12:333. [PMID: 35204833 DOI: 10.3390/biom12020333] [Reference Citation Analysis]
11 Hsu CF, Huang CC, Liu TT, Yang UC, Liu CW, Huang SF, Yang YY, Huang YH, Hou MC, Lin HC. Deletion of intestinal SIRT1 exacerbated muscle wasting in cirrhotic mice by decreasing the intestinal concentration of short-chain fatty acids and inflammation. J Pharmacol Sci 2021;147:376-85. [PMID: 34663520 DOI: 10.1016/j.jphs.2021.09.003] [Reference Citation Analysis]
12 Wu C, Chen Z, Zhang L, Zhu Y, Deng M, Huang C, Liu Y, Zhu Q, Wang L. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway. Hypertens Res 2021;44:168-78. [PMID: 32908237 DOI: 10.1038/s41440-020-00548-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Batchu P, Terrill TH, Kouakou B, Estrada-Reyes ZM, Kannan G. Plasma metabolomic profiles as affected by diet and stress in Spanish goats. Sci Rep 2021;11:12607. [PMID: 34131197 DOI: 10.1038/s41598-021-91893-x] [Reference Citation Analysis]
14 Qi YZ, Jiang YH, Jiang LY, Shao LL, Yang XS, Yang CH. An Insight Into Intestinal Microbiota of Spontaneously Hypertensive Rats After Valsartan Administration. Dose Response 2021;19:15593258211011342. [PMID: 33994888 DOI: 10.1177/15593258211011342] [Reference Citation Analysis]
15 Kalo E, Read S, Ahlenstiel G. Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension. Livers 2021;1:147-79. [DOI: 10.3390/livers1030014] [Reference Citation Analysis]
16 Ziętek M, Celewicz Z, Kikut J, Szczuko M. Implications of SCFAs on the Parameters of the Lipid and Hepatic Profile in Pregnant Women. Nutrients 2021;13:1749. [PMID: 34063900 DOI: 10.3390/nu13061749] [Reference Citation Analysis]
17 Ishimwe JA. Maternal microbiome in preeclampsia pathophysiology and implications on offspring health. Physiol Rep 2021;9:e14875. [PMID: 34042284 DOI: 10.14814/phy2.14875] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Vallianou N, Christodoulatos GS, Karampela I, Tsilingiris D, Magkos F, Stratigou T, Kounatidis D, Dalamaga M. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2022;12:56. [DOI: 10.3390/biom12010056] [Reference Citation Analysis]
19 Bajaj JS, Fan S, Thacker LR, Fagan A, Gavis E, White MB, Heuman DM, Fuchs M, Fiehn O. Serum and urinary metabolomics and outcomes in cirrhosis. PLoS One 2019;14:e0223061. [PMID: 31560724 DOI: 10.1371/journal.pone.0223061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Weiss SL, Zhang D, Farooqi S, Wallace DC. Sodium butyrate reverses lipopolysaccharide-induced mitochondrial dysfunction in lymphoblasts. J Cell Mol Med 2022. [PMID: 35587004 DOI: 10.1111/jcmm.17342] [Reference Citation Analysis]
21 Chen Z, Ruan J, Li D, Wang M, Han Z, Qiu W, Wu G. The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy. Front Cell Infect Microbiol 2020;10:595759. [PMID: 33553004 DOI: 10.3389/fcimb.2020.595759] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
22 Prins GH, Rios-Morales M, Gerding A, Reijngoud DJ, Olinga P, Bakker BM. The Effects of Butyrate on Induced Metabolic-Associated Fatty Liver Disease in Precision-Cut Liver Slices. Nutrients 2021;13:4203. [PMID: 34959755 DOI: 10.3390/nu13124203] [Reference Citation Analysis]